Skip to content
Stories Served, One Cup at a Time.

Voyager Therapeutics: A Promising Future in Neurogenetic Medicine

Photo by Josh Riemer / Unsplash

Voyager Therapeutics, a clinical-stage biotechnology company, is making remarkable strides in the field of neurogenetic medicine. Specializing in gene therapy to address neurological diseases, Voyager is on a mission to leverage human genetics to modify the course of these debilitating conditions and ultimately provide cures. The company’s innovative approaches and robust pipeline position it at the forefront of biotechnology advancements.

Financial Overview

In the first quarter of 2024, Voyager Therapeutics reported collaboration revenues of $19.5 million, down from $150.5 million in the same period in 2023. This decline was primarily due to significant revenue recognition from the Neurocrine Collaboration Agreement and Novartis' exercise of two capsid options in the previous year. Despite this decrease, Voyager’s financial health remains strong. The company completed a public offering, raising approximately $100 million, bolstering its cash reserves to $400.5 million as of March 31, 2024. This strong cash position is expected to sustain Voyager’s operations and development programs into 2027.

Voyager’s research and development (R&D) expenses increased to $27.1 million, reflecting intensified efforts in manufacturing and IND-enabling studies for its promising programs, including the VY-TAU01 anti-tau antibody and the VY9323 SOD1-ALS gene therapy program. General and administrative expenses were slightly reduced to $8.6 million, indicating efficient operational management.

Register to read on. Stays free forever.


Already have an account? Log in


ASML: The Unrivaled Titan of Semiconductor Manufacturing

ASML: The Unrivaled Titan of Semiconductor Manufacturing

ASML, the Dutch company at the heart of semiconductor manufacturing, continues to be a pivotal player in the tech industry. Despite geopolitical challenges and intense competition, ASML remains the sole supplier of the crucial extreme ultraviolet (EUV) lithography machines essential for producing the world's most advanced chips. This

Pesticides in Tea: A Growing Concern in 2024

Pesticides in Tea: A Growing Concern in 2024

In 2024, the issue of pesticide contamination in tea has come to the forefront, prompting recalls and regulatory actions worldwide. The detection of pesticide residues in tea, a beloved beverage enjoyed by millions, has raised significant health and safety concerns. Major Recalls One of the most notable incidents this year